BeiGene (ONC) Revenue

Annual revenue:

$3.81B+$1.35B(+54.96%)
December 31, 2024

Summary

  • As of today (April 12, 2025), ONC annual revenue is $3.81 billion, with the most recent change of +$1.35 billion (+54.96%) on December 31, 2024.
  • During the last 3 years, ONC annual revenue has risen by +$2.63 billion (+223.92%).
  • ONC annual revenue is now at all-time high.

Performance

ONC Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherONCincome statement metrics

Quarterly revenue:

$1.13B+$126.22M(+12.60%)
December 31, 2024

Summary

  • As of today (April 12, 2025), ONC quarterly revenue is $1.13 billion, with the most recent change of +$126.22 million (+12.60%) on December 31, 2024.
  • Over the past year, ONC quarterly revenue has increased by +$493.42 million (+77.78%).
  • ONC quarterly revenue is now at all-time high.

Performance

ONC Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherONCincome statement metrics

TTM revenue:

$3.81B+$493.42M(+14.88%)
December 31, 2024

Summary

  • As of today (April 12, 2025), ONC TTM revenue is $3.81 billion, with the most recent change of +$493.42 million (+14.88%) on December 31, 2024.
  • Over the past year, ONC TTM revenue has increased by +$1.35 billion (+54.96%).
  • ONC TTM revenue is now at all-time high.

Performance

ONC TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherONCincome statement metrics

ONC Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+55.0%+77.8%+55.0%
3 y3 years+223.9%+77.8%+55.0%
5 y5 years+789.8%+77.8%+55.0%

ONC Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+223.9%at high+267.8%at high+334.4%
5 y5-yearat high+1133.6%at high+2066.4%at high+1595.5%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

BeiGene Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$3.81B(+55.0%)
$1.13B(+12.6%)
$3.81B(+14.9%)
Sep 2024
-
$1.00B(+7.8%)
$3.32B(+7.1%)
Jun 2024
-
$929.17M(+23.6%)
$3.10B(+12.1%)
Mar 2024
-
$751.65M(+18.5%)
$2.76B(+12.4%)
Dec 2023
$2.46B(+73.7%)
$634.41M(-18.8%)
$2.46B(+11.5%)
Sep 2023
-
$781.31M(+31.3%)
$2.20B(+21.7%)
Jun 2023
-
$595.26M(+32.9%)
$1.81B(+16.3%)
Mar 2023
-
$447.80M(+17.8%)
$1.56B(+10.0%)
Dec 2022
$1.42B(+20.4%)
-
-
Dec 2022
-
$380.10M(-1.9%)
$1.42B(+13.3%)
Sep 2022
-
$387.63M(+13.5%)
$1.25B(+17.0%)
Jun 2022
-
$341.57M(+11.4%)
$1.07B(+21.8%)
Mar 2022
-
$306.63M(+43.3%)
$877.04M(-25.4%)
Dec 2021
$1.18B(+280.8%)
$213.98M(+3.7%)
$1.18B(+10.7%)
Sep 2021
-
$206.44M(+37.6%)
$1.06B(+12.2%)
Jun 2021
-
$149.99M(-75.2%)
$947.04M(+9.8%)
Mar 2021
-
$605.87M(+505.3%)
$862.69M(+179.3%)
Dec 2020
$308.87M
$100.10M(+9.9%)
$308.87M(+16.3%)
Sep 2020
-
$91.08M(+38.8%)
$265.67M(+18.2%)
Jun 2020
-
$65.64M(+26.1%)
$224.73M(-44.2%)
DateAnnualQuarterlyTTM
Mar 2020
-
$52.06M(-8.5%)
$402.44M(-6.0%)
Dec 2019
$428.21M(+116.0%)
$56.89M(+13.5%)
$428.21M(-0.4%)
Sep 2019
-
$50.14M(-79.4%)
$429.99M(-0.9%)
Jun 2019
-
$243.35M(+212.7%)
$434.05M(+78.2%)
Mar 2019
-
$77.83M(+32.7%)
$243.51M(+22.8%)
Dec 2018
$198.22M(-16.8%)
$58.67M(+8.2%)
$198.22M(+25.7%)
Sep 2018
-
$54.20M(+2.6%)
$157.72M(-51.3%)
Jun 2018
-
$52.80M(+62.3%)
$323.74M(+19.5%)
Mar 2018
-
$32.54M(+79.1%)
$270.93M(+13.7%)
Dec 2017
$238.39M(>+9900.0%)
$18.17M(-91.7%)
$238.39M(+8.3%)
Sep 2017
-
$220.21M(>+9900.0%)
$220.21M(+2989.8%)
Dec 2016
$1.07M(-87.9%)
-
-
Jun 2016
-
$393.00K(-41.9%)
$7.13M(-12.2%)
Mar 2016
-
$677.00K(-85.5%)
$8.11M(-8.0%)
Dec 2015
$8.82M(-32.4%)
$4.68M(+238.9%)
$8.82M(+59.7%)
Sep 2015
-
$1.38M(0.0%)
$5.52M(-48.1%)
Jun 2015
-
$1.38M(+0.1%)
$10.64M(+14.9%)
Mar 2015
-
$1.38M(-0.1%)
$9.26M(+17.5%)
Dec 2014
$13.04M(+16.9%)
$1.38M(-78.7%)
$7.88M(+21.3%)
Sep 2014
-
$6.50M
$6.50M
Dec 2013
$11.15M
-
-

FAQ

  • What is BeiGene annual revenue?
  • What is the all time high annual revenue for BeiGene?
  • What is BeiGene annual revenue year-on-year change?
  • What is BeiGene quarterly revenue?
  • What is the all time high quarterly revenue for BeiGene?
  • What is BeiGene quarterly revenue year-on-year change?
  • What is BeiGene TTM revenue?
  • What is the all time high TTM revenue for BeiGene?
  • What is BeiGene TTM revenue year-on-year change?

What is BeiGene annual revenue?

The current annual revenue of ONC is $3.81B

What is the all time high annual revenue for BeiGene?

BeiGene all-time high annual revenue is $3.81B

What is BeiGene annual revenue year-on-year change?

Over the past year, ONC annual revenue has changed by +$1.35B (+54.96%)

What is BeiGene quarterly revenue?

The current quarterly revenue of ONC is $1.13B

What is the all time high quarterly revenue for BeiGene?

BeiGene all-time high quarterly revenue is $1.13B

What is BeiGene quarterly revenue year-on-year change?

Over the past year, ONC quarterly revenue has changed by +$493.42M (+77.78%)

What is BeiGene TTM revenue?

The current TTM revenue of ONC is $3.81B

What is the all time high TTM revenue for BeiGene?

BeiGene all-time high TTM revenue is $3.81B

What is BeiGene TTM revenue year-on-year change?

Over the past year, ONC TTM revenue has changed by +$1.35B (+54.96%)
On this page